HIV Alert: Novel Strategies and Agents for HIV Management

Listen to downloadable audio from a series of live Webinars by Daniel R. Kuritzkes, MD, and Paul E. Sax, MD, in which potential future HIV treatment strategies—including long-acting ART, dual-therapy regimens, and investigational agents—are discussed and audience questions on this subject are addressed.
Format: Audio (.mp3)
File Size: 38.86 MB
Released: June 21, 2016

Listen to downloadable audio from a series of live Webinars by Daniel R. Kuritzkes, MD, and Paul E. Sax, MD, in which potential future HIV treatment strategies—including long-acting ART, dual-therapy regimens, and investigational agents—are discussed and audience questions on this subject are addressed. (39 minutes)

Daniel R. Kuritzkes, MD, has disclosed that he has received consulting fees from Bionor, Gilead Sciences, GlaxoSmithKline, InnaVirVax, Merck, ViiV.

Paul E. Sax, MD, has disclosed that he has received consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Janssen, Merck, and ViiV and funds for research support from Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, and ViiV.

Acknowledgements

Supported by independent educational grants from
Gilead Sciences
ViiV Healthcare

Related Content

Clinical Care Options’ expert audio analysis of new and emerging strategies to overcome barriers to HIV PrEP uptake, provided by Kenneth Mayer, MD.

Kenneth Mayer, MD Released: February 15, 2019

Downloadable slideset from Clinical Care Options on overcoming barriers to PrEP, with insights from Latesha Elopre, MD, MSPH, and Kenneth Mayer, MD

Latesha Elopre, MD, MSPH Kenneth Mayer, MD Released: February 13, 2019

Downloadable slideset from Clinical Care Options on key aspects of HCV pharmacy service provision, with insights from expert faculty

John Faragon, PharmD, BCPS, AAHIVP
Program Director
Michelle T. Martin, PharmD, FCCP, BCPS, BCACP
Released: February 4, 2019

Watch this CME/CPE video module from Clinical Care Options to learn best practices for pharmacists to assist patients with or at risk for HCV infection

John Faragon, PharmD, BCPS, AAHIVP
Program Director
Michelle T. Martin, PharmD, FCCP, BCPS, BCACP
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Pharmacists: 1.25 contact hours (0.125 CEUs) Released: February 1, 2019 Expiration: January 31, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?